EMEA (Europe, Middle East and Africa) Neurological Biomarkers Market Report 2017

December 2017 | 112 pages | ID: EBC32ABA97BEN
QYResearch

Abstracts

In this report, the EMEA Neurological Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Neurological Biomarkers for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neurological Biomarkers market competition by top manufacturers/players, with Neurological Biomarkers sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Thermo Fisher Scientific (U.S.)
• Qiagen (Germany)
• Myriad RBM (U.S.)
• Proteome Sciences (UK)
• Banyan Biomarkers (U.S.)
• Cisbio Bioassays (U.S.)
• Abiant (U.S.)
• Acumen Pharmaceuticals (U.S.)
• Proteosys (Germany)
• Alseres Pharmaceuticals (U.S.)
• Athena Diagnostics (U.S.)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Alzheimer's Disease
• Parkinson's Disease
• Autism Spectrum Disorder
• Multiple Sclerosis
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Genomics
• Proteomics
• Metabolomics
• Imaging
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Neurological Biomarkers Market Report 2017

1 NEUROLOGICAL BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarkers
1.2 Classification of Neurological Biomarkers
  1.2.1 EMEA Neurological Biomarkers Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Neurological Biomarkers Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Alzheimer's Disease
  1.2.4 Parkinson's Disease
  1.2.5 Autism Spectrum Disorder
  1.2.6 Multiple Sclerosis
  1.2.7 Other
1.3 EMEA Neurological Biomarkers Market by Application/End Users
  1.3.1 EMEA Neurological Biomarkers Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Genomics
  1.3.3 Proteomics
  1.3.4 Metabolomics
  1.3.5 Imaging
  1.3.6 Other
1.4 EMEA Neurological Biomarkers Market by Region
  1.4.1 EMEA Neurological Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Neurological Biomarkers (2012-2022)
  1.5.1 EMEA Neurological Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Neurological Biomarkers Revenue and Growth Rate (2012-2022)

2 EMEA NEUROLOGICAL BIOMARKERS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Neurological Biomarkers Market Competition by Players/Manufacturers
  2.1.1 EMEA Neurological Biomarkers Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Neurological Biomarkers Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Neurological Biomarkers Sale Price by Players (2012-2017)
2.2 EMEA Neurological Biomarkers (Volume and Value) by Type/Product Category
  2.2.1 EMEA Neurological Biomarkers Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Neurological Biomarkers Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Neurological Biomarkers Sale Price by Type (2012-2017)
2.3 EMEA Neurological Biomarkers (Volume) by Application
2.4 EMEA Neurological Biomarkers (Volume and Value) by Region
  2.4.1 EMEA Neurological Biomarkers Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Neurological Biomarkers Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Neurological Biomarkers Sales Price by Region (2012-2017)

3 EUROPE NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Neurological Biomarkers Sales and Value (2012-2017)
  3.1.1 Europe Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Neurological Biomarkers Revenue and Growth Rate (2012-2017)
3.2 Europe Neurological Biomarkers Sales and Market Share by Type
3.3 Europe Neurological Biomarkers Sales and Market Share by Application
3.4 Europe Neurological Biomarkers Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Neurological Biomarkers Sales Volume by Countries (2012-2017)
  3.4.2 Europe Neurological Biomarkers Revenue by Countries (2012-2017)
  3.4.3 Germany Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.4.4 France Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.4.5 UK Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.4.6 Russia Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.4.7 Italy Neurological Biomarkers Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Neurological Biomarkers Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Neurological Biomarkers Sales and Value (2012-2017)
  4.1.1 Middle East Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Neurological Biomarkers Revenue and Growth Rate (2012-2017)
4.2 Middle East Neurological Biomarkers Sales and Market Share by Type
4.3 Middle East Neurological Biomarkers Sales and Market Share by Application
4.4 Middle East Neurological Biomarkers Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Neurological Biomarkers Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Neurological Biomarkers Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Neurological Biomarkers Sales and Growth Rate (2012-2017)
  4.4.4 Israel Neurological Biomarkers Sales and Growth Rate (2012-2017)
  4.4.5 UAE Neurological Biomarkers Sales and Growth Rate (2012-2017)
  4.4.6 Iran Neurological Biomarkers Sales and Growth Rate (2012-2017)

5 AFRICA NEUROLOGICAL BIOMARKERS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Neurological Biomarkers Sales and Value (2012-2017)
  5.1.1 Africa Neurological Biomarkers Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Neurological Biomarkers Revenue and Growth Rate (2012-2017)
5.2 Africa Neurological Biomarkers Sales and Market Share by Type
5.3 Africa Neurological Biomarkers Sales and Market Share by Application
5.4 Africa Neurological Biomarkers Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Neurological Biomarkers Sales Volume by Countries (2012-2017)
  5.4.2 Africa Neurological Biomarkers Revenue by Countries (2012-2017)
  5.4.3 South Africa Neurological Biomarkers Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Neurological Biomarkers Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Neurological Biomarkers Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Neurological Biomarkers Sales and Growth Rate (2012-2017)

6 EMEA NEUROLOGICAL BIOMARKERS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Thermo Fisher Scientific (U.S.)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neurological Biomarkers Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Qiagen (Germany)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Neurological Biomarkers Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Qiagen (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Myriad RBM (U.S.)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Neurological Biomarkers Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Myriad RBM (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Proteome Sciences (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Neurological Biomarkers Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Proteome Sciences (UK) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Banyan Biomarkers (U.S.)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Neurological Biomarkers Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Banyan Biomarkers (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Cisbio Bioassays (U.S.)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Neurological Biomarkers Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Cisbio Bioassays (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abiant (U.S.)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Neurological Biomarkers Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abiant (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Acumen Pharmaceuticals (U.S.)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Neurological Biomarkers Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Proteosys (Germany)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Neurological Biomarkers Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Proteosys (Germany) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Alseres Pharmaceuticals (U.S.)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Neurological Biomarkers Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Athena Diagnostics (U.S.)

7 NEUROLOGICAL BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Neurological Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neurological Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neurological Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEUROLOGICAL BIOMARKERS MARKET FORECAST (2017-2022)

11.1 EMEA Neurological Biomarkers Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Neurological Biomarkers Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Neurological Biomarkers Price and Trend Forecast (2017-2022)
11.2 EMEA Neurological Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Neurological Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Neurological Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Neurological Biomarkers Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Neurological Biomarkers Sales Forecast by Type (2017-2022)
11.7 EMEA Neurological Biomarkers Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neurological Biomarkers
Figure EMEA Neurological Biomarkers Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Neurological Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Alzheimer's Disease Product Picture
Figure Parkinson's Disease Product Picture
Figure Autism Spectrum Disorder Product Picture
Figure Multiple Sclerosis Product Picture
Figure Other Product Picture
Figure EMEA Neurological Biomarkers Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Neurological Biomarkers by Application in 2016
Figure Genomics Examples
Table Key Downstream Customer in Genomics
Figure Proteomics Examples
Table Key Downstream Customer in Proteomics
Figure Metabolomics Examples
Table Key Downstream Customer in Metabolomics
Figure Imaging Examples
Table Key Downstream Customer in Imaging
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Neurological Biomarkers Market Size (Million USD) by Region (2012-2022)
Figure Europe Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neurological Biomarkers Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Neurological Biomarkers Revenue (Million USD) Status and Forecast by Countries
Figure Africa Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Neurological Biomarkers Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Neurological Biomarkers Sales Volume and Growth Rate (2012-2022)
Figure EMEA Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Neurological Biomarkers Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Neurological Biomarkers Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Neurological Biomarkers Sales Share by Players (2012-2017)
Figure 2016 Neurological Biomarkers Sales Share by Players
Figure 2017 Neurological Biomarkers Sales Share by Players
Figure EMEA Neurological Biomarkers Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Neurological Biomarkers Revenue (Million USD) by Players (2012-2017)
Table EMEA Neurological Biomarkers Revenue Share by Players (2012-2017)
Table 2016 EMEA Neurological Biomarkers Revenue Share by Players
Table 2017 EMEA Neurological Biomarkers Revenue Share by Players
Table EMEA Neurological Biomarkers Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Neurological Biomarkers Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Neurological Biomarkers Sales Share by Type (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Type (2012-2017)
Figure EMEA Neurological Biomarkers Sales Market Share by Type (2012-2017)
Table EMEA Neurological Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Neurological Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Type in 2016
Table EMEA Neurological Biomarkers Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Neurological Biomarkers Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Neurological Biomarkers Sales Share by Application (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Application (2012-2017)
Figure EMEA Neurological Biomarkers Sales Market Share by Application in 2016
Table EMEA Neurological Biomarkers Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Neurological Biomarkers Sales Share by Region (2012-2017)
Figure Sales Market Share of Neurological Biomarkers by Region (2012-2017)
Figure EMEA Neurological Biomarkers Sales Market Share in 2016
Table EMEA Neurological Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Neurological Biomarkers Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Neurological Biomarkers by Region (2012-2017)
Figure EMEA Neurological Biomarkers Revenue Market Share Regions in 2016
Table EMEA Neurological Biomarkers Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Neurological Biomarkers Revenue and Growth Rate (2012-2017)
Table Europe Neurological Biomarkers Sales (K Pcs) by Type (2012-2017)
Table Europe Neurological Biomarkers Market Share by Type (2012-2017)
Figure Europe Neurological Biomarkers Market Share by Type in 2016
Table Europe Neurological Biomarkers Sales (K Pcs) by Application (2012-2017)
Table Europe Neurological Biomarkers Market Share by Application (2012-2017)
Figure Europe Neurological Biomarkers Market Share by Application in 2016
Table Europe Neurological Biomarkers Sales (K Pcs) by Countries (2012-2017)
Table Europe Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Europe Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Europe Neurological Biomarkers Sales Market Share by Countries in 2016
Table Europe Neurological Biomarkers Revenue (Million USD) by Countries (2012-2017)
Table Europe Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Europe Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Germany Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Neurological Biomarkers Sales (K Pcs) by Type (2012-2017)
Table Middle East Neurological Biomarkers Market Share by Type (2012-2017)
Figure Middle East Neurological Biomarkers Market Share by Type (2012-2017)
Table Middle East Neurological Biomarkers Sales (K Pcs) by Applications (2012-2017)
Table Middle East Neurological Biomarkers Market Share by Applications (2012-2017)
Figure Middle East Neurological Biomarkers Sales Market Share by Application in 2016
Table Middle East Neurological Biomarkers Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Neurological Biomarkers Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Neurological Biomarkers Sales Volume Market Share by Countries in 2016
Table Middle East Neurological Biomarkers Revenue (Million USD) by Countries (2012-2017)
Table Middle East Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Middle East Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Middle East Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Neurological Biomarkers Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Neurological Biomarkers Sales (K Pcs) by Type (2012-2017)
Table Africa Neurological Biomarkers Sales Market Share by Type (2012-2017)
Figure Africa Neurological Biomarkers Sales Market Share by Type (2012-2017)
Figure Africa Neurological Biomarkers Sales Market Share by Type in 2016
Table Africa Neurological Biomarkers Sales (K Pcs) by Application (2012-2017)
Table Africa Neurological Biomarkers Sales Market Share by Application (2012-2017)
Figure Africa Neurological Biomarkers Sales Market Share by Application (2012-2017)
Table Africa Neurological Biomarkers Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Africa Neurological Biomarkers Sales Market Share by Countries (2012-2017)
Figure Africa Neurological Biomarkers Sales Market Share by Countries in 2016
Table Africa Neurological Biomarkers Revenue (Million USD) by Countries (2012-2017)
Table Africa Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Africa Neurological Biomarkers Revenue Market Share by Countries (2012-2017)
Figure Africa Neurological Biomarkers Revenue Market Share by Countries in 2016
Figure South Africa Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Basic Information List
Table Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Qiagen (Germany) Neurological Biomarkers Basic Information List
Table Qiagen (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Qiagen (Germany) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Myriad RBM (U.S.) Neurological Biomarkers Basic Information List
Table Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Myriad RBM (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Proteome Sciences (UK) Neurological Biomarkers Basic Information List
Table Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Proteome Sciences (UK) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Basic Information List
Table Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Banyan Biomarkers (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Basic Information List
Table Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Cisbio Bioassays (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Abiant (U.S.) Neurological Biomarkers Basic Information List
Table Abiant (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Abiant (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Basic Information List
Table Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Acumen Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Proteosys (Germany) Neurological Biomarkers Basic Information List
Table Proteosys (Germany) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Proteosys (Germany) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Basic Information List
Table Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales (K Pcs) and Growth Rate (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Sales Market Share in EMEA (2012-2017)
Figure Alseres Pharmaceuticals (U.S.) Neurological Biomarkers Revenue Market Share in EMEA (2012-2017)
Table Athena Diagnostics (U.S.) Neurological Biomarkers Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarkers
Figure Manufacturing Process Analysis of Neurological Biomarkers
Figure Neurological Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarkers Major Manufacturers in 2016
Table Major Buyers of Neurological Biomarkers
Table Distributors/Traders List
Figure EMEA Neurological Biomarkers Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Neurological Biomarkers Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Neurological Biomarkers Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Neurological Biomarkers Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Neurological Biomarkers Sales Market Share Forecast by Region (2017-2022)
Table EMEA Neurological Biomarkers Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Neurological Biomarkers Revenue Market Share Forecast by Region (2017-2022)
Table Europe Neurological Biomarkers Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Neurological Biomarkers Sales Market Share Forecast by Countries (2017-2022)
Table Europe Neurological Biomarkers Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Neurological Biomarkers Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Neurological Biomarkers Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Neurological Biomarkers Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Neurological Biomarkers Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Neurological Biomarkers Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Neurological Biomarkers Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Neurological Biomarkers Sales Market Share Forecast by Countries (2017-2022)
Table Africa Neurological Biomarkers Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Neurological Biomarkers Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Neurological Biomarkers Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Neurological Biomarkers Sales Market Share Forecast by Type (2017-2022)
Table EMEA Neurological Biomarkers Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Neurological Biomarkers Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources